Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Yi Zhang"'
Autor:
Shiying Dang, Lin Chen, Xiao-Yong Zhan, Fei Yin, Ke Huang, Yun Li, Yang Kang, Yuhong Liang, Nan Wang, Tianshun Gao, Xing Xiao, Yi Zhang, Bihui Huang, Nannan Lai, Changfei Qin, Chuanming Luo, Yang Leng
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology, Vol 11 (2021)
Lung cancer is one of the most common and mortal malignancies, usually with a poor prognosis in its advanced or recurrent stages. Recently, immune checkpoint inhibitors (ICIs) immunotherapy has revolutionized the treatment of human cancers including
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
The CD71+ erythroid progenitor cells (CECs) exhibit distinctive immunosuppressive properties and regulate antitumor immunity to enable tumor growth. We presented a novel and non-invasive approach to improving immunity by targeting the splenic CECs vi
Autor:
Dan Zou, Jin Bai, Enting Lu, Chunjiao Yang, Jiaqing Liu, Zhenpeng Wen, Xuqin Liu, Zi Jin, Mengdan Xu, Lei Jiang, Ye Zhang, Yi Zhang
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Epithelial ovarian cancer (EOC) has a poor prognosis and high mortality rate; patients are easy to relapse with standard therapies. So, there is an urgent need to develop novel drugs. In this study, differentially expressed genes (DEGs) of EOC were i
Autor:
Lixin Sun, Ping Liu, Chunlin Chen, Jianxin Guo, Danbo Wang, Wenling Zhang, Hongwei Zhao, Jinghe Lang, Li Wang, Yi Zhang, Zhumei Cui, Ying Yang, Weili Li, Xiaonong Bin, Wuliang Wang
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
ObjectiveTo compare the 5-year overall survival (OS) and disease-free survival (DFS) of patients with cervical cancer who received neoadjuvant chemotherapy followed by surgery (NACT) with those who received abdominal radical hysterectomy alone (ARH).
Autor:
Qingsong Li, Na Liang, Xia Zhang, Yi Zhang, Weiwei Ouyang, Shengfa Su, Zhu Ma, Yinxiang Hu, Yichao Geng, Xiaxia Chen, Bing Lu
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology, Vol 11 (2021)
PurposeThe aim of this study was to investigate the reasonable timing of radiotherapy for stage IV non-small-cell lung cancer (NSCLC) with EGFR-positive mutations during targeted therapy based on tumour volume change (TVC).Patients and MethodsSimulat
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology, Vol 11 (2021)
ObjectiveAs a result of the inconsistency between reports, a meta-analysis was designed to appraise the clinical implications of long non-coding RNAs (lncRNAs) in exosomes for the diagnosis of bladder cancer.MethodsThe PubMed, EMBASE, and Cochrane li
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology, Vol 11 (2021)
Cancer of unknown primary (CUP), in which metastatic diseases exist without an identifiable primary location, accounts for about 3–5% of all cancer diagnoses. Successful diagnosis and treatment of such patients are difficult. This study aimed to as
Autor:
Junsheng Zhang, Ciqiu Yang, Yi Zhang, Fei Ji, Hongfei Gao, Xiaosheng Zhuang, Weiping Li, Weijun Pan, Bo Shen, Tingfeng Zhang, Yuanqi Chen, Kun Wang
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
BackgroundThe influence of surgical approaches [including mastectomy, breast-conserving therapy (BCT) and post-mastectomy breast reconstruction (PMBR) on prognosis of young women (MethodsWe used the Surveillance, Epidemiology, and End Results (SEER)
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
This study aims to analyze the methylation regulation of TLR3 in lung adenocarcinoma (LUAD) and to explore the association of TLR3 expression with immune microenvironment. TLR3 has a decreased expression in LUAD tissues and low expression of TLR3 is
Autor:
Ke Bi, De-meng Xia, Lin Fan, Xiao-fei Ye, Yi Zhang, Meng-jun Shen, Hong-wei Chen, Yang Cong, Hui-ming Zhu, Chun-hong Tang, Jing Yuan, Yin Wang
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
ObjectiveTo develop and prospective validate an ultrasound (US) prediction model to differentiate between benign and malignant subpleural pulmonary lesions (SPLs).MethodsThis study was conducted retrospectively from July 2017 to December 2018 (develo